Breaking News Instant updates and real-time market news.

BUD

AB InBev

$68.95

0.17 (0.25%)

, TLRY

Tilray

$71.00

-5.77 (-7.52%)

16:31
12/19/18
12/19
16:31
12/19/18
16:31

AB InBev, Tilray form research partnership over non-alcohol THC, CBD beverages

AB InBev (BUD) and Tilray (TLRY) announced a partnership to research non-alcohol beverages containing tetrahydrocannabinol and cannabidiol. The partnership is limited to Canada and decisions regarding the commercialization of the beverages will be made in the future. The research partnership combines AB InBev's deep experience in beverages with Tilray's expertise in cannabis products. AB InBev's participation will be through its subsidiary Labatt Breweries of Canada, one of the country's founding businesses and its leading brewery, and Tilray's participation will be through its Canadian adult-use cannabis subsidiary High Park company, which develops, sells, and distributes a portfolio of socially responsible cannabis brands and products in Canada. Each company intends to invest up to $50M, for a total of up to $100M.

BUD

AB InBev

$68.95

0.17 (0.25%)

TLRY

Tilray

$71.00

-5.77 (-7.52%)

BUD AB InBev
$68.95

0.17 (0.25%)

12/11/18
OTRG
12/11/18
NO CHANGE
OTRG
MillerCoors and ABI Q4 trends lag overall US beer category, says OTR Global
OTR Global's US beer Q4 distributor checks indicate MillerCoors (TAP) and ABI (BUD) volumes lagged the overall beer category. The firm said domestic premium light beers continued to struggle, while flavored malt beverages and imports boosted overall beer volumes.
11/12/18
11/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Hold om Buy at SunTrust with analyst Matthew Thornton citing a surprising and disappointing set of Q3 results following a "stellar" first half of 2018, highlighted by the return of sales execution issues, yielding an unexpected slowdown in gross account adds and continued churn. 2. Cheesecake Factory (CAKE) downgraded to Underweight from Equal Weight at Barclays with analyst Jeffrey Bernstein saying he sees headwinds persisting following the company's "disappointing" Q3 results and views the valuation as full at current share levels. 3. Infinity Pharmaceuticals (INFI) downgraded to Underweight from Neutral at JPMorgan and to Market Perform at Wells Fargo. 4. Skyworks (SWKS) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying the company is being impacted by broad smartphone weakness, disappointing unit sales of Apple's (AAPL) iPhone XR, and a high Apple concentration, which represented 39% of sales in fiscal 2019. 5. AB InBev (BUD) downgraded to Hold from Buy at Argus with analyst David Coleman citing the company's dividend cut, which he believes reduces the attraction of the stock to income investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/18
ARGS
11/12/18
DOWNGRADE
ARGS
Hold
AB InBev downgraded to Hold from Buy at Argus
Argus analyst David Coleman downgraded Anheuser-Busch In Bev to Hold from Buy after the company cut the dividend in half, which he believes reduces the attraction of the stock to income investors. He also said the company has been "erratic" on earnings, noting that AB InBev has missed forecasts in three of the past five quarters.
10/31/18
10/31/18
DOWNGRADE

Neutral
AB InBev downgraded to Neutral following dividend cut at Macquarie
As previously reported, Macquarie downgraded AB InBev to Neutral from Outperform and cut its price target to $75 from $92. Following the halving of the dividend, analyst Caroline Levy said shares are no longer a compelling yield investment at 2.7% dividend yield. Levy said AB InBev still faces challenging EM markets, weak North American demand, and drags in 2019 from FX/cost inputs.
TLRY Tilray
$71.00

-5.77 (-7.52%)

12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.
11/14/18
BNCH
11/14/18
NO CHANGE
Target $200
BNCH
Buy
Tilray reported 'strong' Q3 sales without recreational cannabis, says Benchmark
Benchmark analyst Mike Hickey said Tilray reported "strong" Q3 sales even though the company did not recognize sales from recreational cannabis use in the quarter. Recreational use experienced a slow start, primarily due to the timing of licenses, distribution and retail infrastructure, as expected, said Hickey, who adds that there "appears to be exceedingly strong demand" from Canadians. He has raised his Q4 sales forecast based on increased production and presumed ongoing strong consumer demand and keeps a Buy rating on Tilray with a $200 price target.
11/07/18
ADAM
11/07/18
NO CHANGE
ADAM
Midterms broadly positive for U.S. cannabis industry, says Canaccord
Canaccord analyst Bobby Burleson says that as expected, yesterday's midterms delivered several wins for the U.S. cannabis industry, including the passage of three state ballot measures on legalization, key gubernatorial victories by pro-cannabis candidates, and the retaking of the House by Democrats. The analyst views these results as broadly positive for the U.S. cannabis industry. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC) and Tilray (TLRY).
11/06/18
COWN
11/06/18
NO CHANGE
COWN
Demand for adult use cannabis 'seemingly strong' in Canada, says Cowen
Citing her analysis of e-commerce platforms for adult use cannabis in Canada, Cowen analyst Vivien Azer remains encouraged to see "seemingly strong demand" as well as some instances of improved supply. In a research note pre-market open, the analyst notes she aggregated 533 product offerings with 1,149 SKUs from the e-commerce platforms for Alberta, British Columbia, Ontario, New Brunswick, and Newfoundland and Labrador. Overall, SKU stockout rates across the provinces were flat versus last week at 57%, although remains above the 46% rate during the prior week, Azer adds. Her view of the data is a modest positive for Canopy Growth (CGC), which has the second highest number of SKUs and out of stock rates declined from 65% to 54% while adding 16 SKUs this week. The read-through on Tilray (TLRY) is less clear, Azer contends, as the only three provinces where the company did not get supply agreements were all in her five province survey universe. The analyst reiterated an Outperform rating on Canopy Growth and Tilray.

TODAY'S FREE FLY STORIES

KPLUF

K+S

$0.00

(0.00%)

05:34
10/14/19
10/14
05:34
10/14/19
05:34
Downgrade
K+S rating change  »

K+S downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVACF

Avance Gas

$0.00

(0.00%)

05:32
10/14/19
10/14
05:32
10/14/19
05:32
Upgrade
Avance Gas rating change  »

Avance Gas upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPG

Dorian LPG

$11.48

0.22 (1.95%)

05:30
10/14/19
10/14
05:30
10/14/19
05:30
Upgrade
Dorian LPG rating change  »

Dorian LPG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$43.58

(0.00%)

, PFE

Pfizer

$36.11

0.31 (0.87%)

05:25
10/14/19
10/14
05:25
10/14/19
05:25
Hot Stocks
AstraZeneca, Pfizer, Takeda Pharmaceutical enter collaboration with ImaginAb »

ImaginAb announced the…

AZN

AstraZeneca

$43.58

(0.00%)

PFE

Pfizer

$36.11

0.31 (0.87%)

TAK

Takeda Pharmaceutical

$17.29

0.21 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

GS

Goldman Sachs

$204.70

4.85 (2.43%)

, MS

Morgan Stanley

$41.94

0.92 (2.24%)

05:22
10/14/19
10/14
05:22
10/14/19
05:22
Recommendations
Goldman Sachs, Morgan Stanley, E-Trade analyst commentary  »

Hard for Goldman, Morgan…

GS

Goldman Sachs

$204.70

4.85 (2.43%)

MS

Morgan Stanley

$41.94

0.92 (2.24%)

ETFC

E-Trade

$39.49

0.53 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 10

    Nov

  • 12

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:21
10/14/19
10/14
05:21
10/14/19
05:21
Hot Stocks
Genentech says Phase III PEMPHIX study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 06

    Nov

INCY

Incyte

$76.14

0.38 (0.50%)

05:16
10/14/19
10/14
05:16
10/14/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte data enchances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

MELI

MercadoLibre

$554.23

11.5 (2.12%)

05:11
10/14/19
10/14
05:11
10/14/19
05:11
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 17

    Dec

PLNT

Planet Fitness

$58.63

0.94 (1.63%)

05:09
10/14/19
10/14
05:09
10/14/19
05:09
Upgrade
Planet Fitness rating change  »

Planet Fitness upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:06
10/14/19
10/14
05:06
10/14/19
05:06
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

05:05
10/14/19
10/14
05:05
10/14/19
05:05
Upgrade
LeMaitre rating change  »

LeMaitre upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

05:03
10/14/19
10/14
05:03
10/14/19
05:03
Initiation
IGM Biosciences initiated  »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:01
10/14/19
10/14
05:01
10/14/19
05:01
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PING

Ping Identity

$16.47

0.45 (2.81%)

04:58
10/14/19
10/14
04:58
10/14/19
04:58
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

04:57
10/14/19
10/14
04:57
10/14/19
04:57
Initiation
Envista initiated  »

Envista initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$124.41

0.98 (0.79%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

ZLAB

Zai Lab

$32.38

0.01 (0.03%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Zai Lab participates in a conference call with JPMorgan »

SMid Biotechnology Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

SAN

Banco Santander

$4.10

0.155 (3.93%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Banco Santander management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Evercore REITs analyst to hold a luncheon »

REITs Analyst Sakwa holds…

WORK

Slack Technologies

$25.99

2.215 (9.32%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Slack Technologies management to meet with »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

MDLA

Medallia

$29.47

1.365 (4.86%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Medallia management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

CRNCY

Cairn Energy

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Cairn Energy management to meet with Bergenberg »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.